Atlas Trials

Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Keratosis

Clinical trial NCT05136144 · UNKNOWN

Trial details

NCT number
NCT05136144
Sponsor
DermBiont, Inc.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Seborrheic Keratosis
Start date
2021-10-19
Primary completion
2024-05-31
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.